Immunological response of sheep to injections of plasmids encoding Toxoplasma gondii SAG1 and ROP1 genes

Parasite Immunology

Volumn 32, Issue 9-10, 2010, Pages 671-683

  Li, B ^a   Oledzka, G ^b   McFarlane, R G ^a   Spellerberg, M B ^c   Smith, S M ^c   Gelder, F B ^d   Kur, J ^e   Stankiewicz, M ^a  

^a LINCOLN UNIVERSITY   (New Zealand)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

^c CANTERBURY HEALTH LABORATORIES   (New Zealand)

^d Virionyx Corporation Ltd   (New Zealand)

^e GDANSK UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

antibodies; cocktail vaccine; DNA vaccine; IFN ; sheep; Toxoplasma gondii

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; PLASMID DNA; PROTOZOAL RNA; RECOMBINANT ANTIGEN;

ANIMAL EXPERIMENT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE SEQUENCE; HUMORAL IMMUNITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; PRIORITY JOURNAL; PROTOZOAL GENETICS; PROTOZOAL INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SHEEP; TACHYZOITE; TOXOPLASMA GONDII;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIBODY SPECIFICITY; ANTIGENS, PROTOZOAN; CELLS, CULTURED; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; IMMUNIZATION SCHEDULE; IMMUNOGLOBULIN G; INJECTIONS, INTRAMUSCULAR; INTERFERON-GAMMA; MEMBRANE PROTEINS; OLIGODEOXYRIBONUCLEOTIDES; PLASMIDS; PROTOZOAN PROTEINS; PROTOZOAN VACCINES; RECOMBINANT PROTEINS; SHEEP; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL; VACCINATION; VACCINES, DNA;

OVIS; OVIS ARIES; PROTOZOA; TOXOPLASMA; TOXOPLASMA GONDII;

EID: 77955452829     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/j.1365-3024.2010.01228.x     Document Type: Article

References (47)

1. Tenter AM, Heckeroth AR Weiss LM. Toxoplasma gondii: from animals to humans. Int J Parasitol 2000 30 : 1217 1258.
2. Williams RH, Morley EK, Hughes JM, et al. High levels of congenital transmission of Toxoplasma gondii in longitudinal and cross-sectional studies on sheep farms provides evidence of vertical transmission in ovine hosts. Parasitology 2005 130 : 301 307.
3. West DM. Ovine abortion in New Zealand. N Z Vet J 2002 50 : S93 S95.
4. Buxton D. Protozoan infections (Toxoplasma gondii, Neospora caninum and Sarcocystis spp.) in sheep and goats: recent advances. Vet Res 1998 29 : 289 310.
5. Suzuki Y, Orellana MA, Schreiber RD Remington JS. Interferon-gamma: the major mediator of resistance against Toxoplasma gondii. Science 1988 240 : 516 518.
6. Gazzinelli RT, Xu Y, Heiny S, Cheever A Sher A. Simultaneous depletion of CD4+ and CD8+ T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii. J Immunol 1992 149 : 175 180.
7. Wilkins MF O'Connell E. Vaccination of sheep against Toxoplasma abortion. Surveillance 1992 19 : 20 23.
8. Wilkins MF, O'Connell E Te PungaWA. Toxoplasmosis in sheep III. Further evaluation of the ability of a live Toxoplasma gondii vaccine to prevent lamb losses and reduce congenital infection following experimental oral challenge. N Z Vet J 1988 36 : 86 89.
9. Gregersen J. DNA vaccines. Naturwissenschaften 2001 88 : 504 513.
10. Huygen K. Plasmid DNA vaccination. Microbes Infect 2005 7 : 932 938.
11. Moore AC Hill AV. Progress in DNA-based heterologous prime-boost immunization strategies for malaria. Immunol Rev 2004 199 : 126 143.
12. Iborra S, Soto M, Carrion J, Alonso C Requena JM. Vaccination with a plasmid DNA cocktail encoding the nucleosomal histones of Leishmania confers protection against murine cutaneous leishmaniosis. Vaccine 2004 22 : 3865 3876.
13. Siddiqui AA, Pinkston JR, Quinlin ML, et al. Characterization of the immune response to DNA vaccination strategies for schistosomiasis candidate antigen, Sm-p80 in the baboon. Vaccine 2005 23 : 1451 1456.
14. Angus CW, Klivington-Evans D, Dubey JP Kovacs JA. Immunization with a DNA plasmid encoding the SAG1 (P30) protein of Toxoplasma gondii is immunogenic and protective in rodents. J Infect Dis 2000 181 : 317 324.
15. Couper KN, Nielsen HV, Petersen E, Roberts F, Roberts CW Alexander J. DNA vaccination with the immunodominant tachyzoite surface antigen (SAG-1) protects against adult acquired Toxoplasma gondii infection but does not prevent maternofoetal transmission. Vaccine 2003 21 : 2813 2820.
16. Mevelec MN, Bout D, Desolme B, et al. Evaluation of protective effect of DNA vaccination with genes encoding antigens GRA4 and SAG1 associated with GM-CSF plasmid, against acute, chronical and congenital toxoplasmosis in mice. Vaccine 2005 22-23 : 4489 4499.
17. Fachado A, Rodriguez A, Angel SO, et al. Protective effect of a naked DNA vaccine cocktail against lethal toxoplasmosis in mice. Vaccine 2003 21 : 1327 1335.
18. Vercammen M, Scorza T, Huygen K, et al. DNA vaccination with genes encoding Toxoplasma gondii antigens GRA1, GRA7, and ROP2 induces partially protective immunity against lethal challenge in mice. Infect Immun 2000 68 : 38 45.
19. Bivas-Benita M, Laloup M, Versteyhe S, et al. Generation of Toxoplasma gondii GRA1 protein and DNA vaccine loaded chitosan particles: preparation, characterization, and preliminary in vivo studies. Int J Pharm 2003 266 : 17 27.
20. Desolme B, Mevelec MN, Buzoni-Gatel D Bout D. Induction of protective immunity against toxoplasmosis in mice by DNA immunization with a plasmid encoding Toxoplasma gondii GRA4 gene. Vaccine 2000 18 : 2512 2521.
21. Guo H, Chen G, Lu F, Chen H Zheng H. Immunity induced by DNA vaccine of plasmid encoding the rhoptry protein 1 gene combined with the genetic adjuvant of pcIFN-gamma against Toxoplasma gondii in mice. Chin Med J 2001 114 : 317 320.
22. Leyva R, Herion P Saavedra R. Genetic immunization with plasmid DNA coding for the ROP2 protein of Toxoplasma gondii. Parasitol Res 2001 87 : 70 79.
23. Mishima M, Xuan X, Yokoyama N, et al. Recombinant feline herpesvirus type 1 expressing Toxoplasma gondii ROP2 antigen inducible protective immunity in cats. Parasitol Res 2002 88 : 144 149.
24. Ismael AB, Sekkai D, Collin C, Bout D Mevelec MN. The MIC3 gene of Toxoplasma gondii is a novel potent vaccine candidate against toxoplasmosis. Infect Immun 2003 71 : 6222 6228.
25. Barouch DH, Letvin NL Seder RA. The role of cytokine DNAs as vaccine adjuvants for optimizing cellular immune response. Immunol Rev 2004 202 : 266 274.
26. Klinman DM, Yamshchikov G Ishigatsubo Y. Contribution of CpG motifs to the immunogenicity of DNA vaccines. J Immunol 1997 158 : 3635 3639.
27. Scheerlinck JY, Casey G, McWaters P, et al. The immune response to a DNA vaccine can be modulated by co-delivery of cytokine genes using a DNA prime-protein boost strategy. Vaccine 2001 19 : 4053 4060.
28. El-Malky M, Shaohong L, Kumagai T, et al. Protective effect of vaccination with Toxoplasma lysate antigen and CpG as an adjuvant against Toxoplasma gondii in susceptible C57BL/6 mice. Microbiol Immunol 2005 49 : 639 646.
29. Hiszczynska-Sawicka E, Brillowska-Dabrowska A, Dabrowski S, Pietkiewicz H, Myjak P Kur J. High yield expression and single-step purification of Toxoplasma gondii SAG1, GRA1, and GRA7 antigens in Escherichia coli. Protein Expr Purif 2003 27 : 150 157.
30. Khan IA, Ely KH Kasper LH. A purified parasite antigen (p30) mediates CD8 + T cell immunity against fatal Toxoplasma gondii infection in mice. J Immunol 1991 147 : 3501 3506.
31. Pontarollo RA, Rankin R, Babiuk LA, et al. Monocytes are required for optimum in vitro stimulation of bovine peripheral blood mononuclear cells by non-methylated CpG motifs. Vet Immunol Immunopathol 2002 84 : 43 59.
32. Sayles PC, Gibson GW Johnson LL. B cells are essential for vaccination-induced resistance to virulent Toxoplasma gondii. Infect Immun 2000 68 : 1026 1033.
33. Rodgers L, Wang X, Wen X, Dunford B, Miller R Suzuki Y. Strains of Toxoplasma gondii used for tachyzoite antigens to stimulate spleen cells of infected mice in vitro affect cytokine responses of the cells in the culture. Parasitol Res 2005 97 : 332 335.
34. Letscher-Bru V, Pfaff AW, Abou-Bacar A, et al. Vaccination with Toxoplasma gondii SAG-1 protein is protective against congenital toxoplasmosis in BALB/c mice but not in CBA/J mice. Infect Immun 2003 71 : 6615 6619.
35. Baruch DI, Gamain B Miller LH. DNA immunization with the cysteine-rich interdomain region 1 of the Plasmodium faciparum variant antigen elicits limited cross-reactive antibody responses. Infect Immun 2003 71 : 4536 4543.
36. Sedegah M, Charoenvit Y, Minh L, et al. Reduced immunogenicity of DNA vaccine plasmids in mixtures. Gene Ther 2004 11 : 448 456.
37. Kedl RM, Rees WA, Hildeman DA, et al. T cells compete for access to antigen-bearing antigen-presenting cells. J Exp Med 2000 192 : 1105 1113.
38. Sedegah M, Charoenvit Y, Aguiar J, et al. Effect on antibody and T-cell responses of mixing five GMP-produced DNA plasmids and administration with plasmid expressing GM-CSF. Genes Immun 2004 5 : 553 561.
39. Jongert E, de Craeye S, Dewit J Huygen K. GRA7 provides protective immunity in cocktail DNA vaccines against Toxoplasma gondii. Parasite Immunol 2007 29 : 445 453.
40. Kringel H, Dubey JP, Beshah E, Hecker R Urban JFJ. CpG- oligodeoxynucleotides enhance porcine immunity to Toxoplasma gondii. Vet Parasitol 2004 123 : 55 66.
41. Saavedra R, Leyva R, Tenorio EP, et al. CpG-containing ODN has a limited role in the protection against Toxoplasma gondii. Parasite Immunol 2004 26 : 67 73.
42. Hiszczyńska-Sawicka E, Hong L, Xu JB, et al. Comparison of immune response in sheep immunized with DNA vaccine encoding Toxoplasma gondii GRA7 antigen in different adjuvant formulations. Exp Parasitol 2010 124 : 365 372.
43. Dunachie SJ Hill AV. Prime-boost strategies for malaria vaccine development. J Exp Biol 2003 206 : 3771 3779.
44. Ramiro MJ, Zarate JJ, Hanke T, et al. Protection in dogs against visceral leishmaniasis caused by Leishmania infantum is achieved by immunization with a heterologous prime-boost regime using DNA and vaccinia recombinant vectors expressing LACK. Vaccine 2003 21 : 2474 2484.
45. Da'Dara AA, Skelly PJ, Walker CM Harn DA. A DNA-prime/protein-boost vaccination regimen enhances Th2 immune responses but not protection following Schistosoma mansoni infection. Parasite Immunol 2003 25 : 429 437.
46. Rose RD, Tennent J, McWaters P, et al. Efficacy of DNA vaccination by different routes of immunisation in sheep. Vet Immunol Immunopathol 2002 90 : 55 63.
47. Mumper RJ Cui Z. Genetic immunization by jet injection of targeted pDNA-coated nanoparticles. Methods 2003 31 : 255 262.